Benlysta and SLE
Links shared publicly online about this topic
FDA approves Benlysta for SLE, Horizant for RLS - - Drug Topics
drugtopics.modernmedicine.com — “Systemic lupus erythematosus is a serious, potentially fatal autoimmune disease that affects between 300,000 to 1.5 million Americans of all races. Restless legs syndrome is a disruptive neurologic disorder that affects up to 10% of all Americans.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 14, 2011 at 4:24 pm By:
FDA approves Benlysta for SLE, Horizant for RLS: Systemic lupus erythematosus is a serious, potentially fatal au... http://t.co/w7lzkW8
FDA approves Benlysta for SLE, Horizant for RLS - - Drug Topics
drugtopics.modernmedicine.com — “Systemic lupus erythematosus is a serious, potentially fatal autoimmune disease that affects between 300,000 to 1.5 million Americans of all races. Restless legs syndrome is a disruptive neurologic disorder that affects up to 10% of all Americans.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 13, 2011 at 4:09 am By:
Drugs and Devices OW OW Health
FDA approves Benlysta for SLE, Horizant for RLS: Systemic lupus erythematosus is a serious, potentially fatal au... http://t.co/2yvpXCZ
Benlysta Approved (Finally) for SLE - Pathophilia
bmartinmd.com — “Benlysta Approved (Finally) for SLE - Pathophilia” View full resource at bmartinmd.com
Most Recently Shared on March 10, 2011 at 5:47 pm By:
Barbara J. Martin Doctor, Neurologist, and Physician
Benlysta Approved (Finally) for SLE: I wrote about the "Belimumab Buzz" as a top 10 story of 2009. Now, some 14 ... http://bit.ly/gHqkEs
EC grants marketing authorization for BENLYSTA to treat SLE
news-medical.net — “GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Commission has granted marketing authorization for BENLYSTA 10mg/kg as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.” View full resource at news-medical.net
Most Recently Shared on July 14, 2011 at 11:34 am By:
EC grants marketing authorization for BENLYSTA to treat SLE: GlaxoSmithKline and Human Genome Sciences, Inc. ann... http://bit.ly/pyXn1u
RxEconsult, LLC - Benlysta (belimumab) for systemic lupus erythematosus (SLE)
rxeconsult.com — “RxEconsult, LLC - Benlysta (belimumab) for systemic lupus erythematosus (SLE)” View full resource at rxeconsult.com
Most Recently Shared on October 7, 2011 at 11:44 pm By:
RxEconsult. If you are in need of healthcare services or information, please visit RxEconsult.
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD
#Benlysta (#belimumab) for systemic #lupus erythematosus (SLE) http://t.co/3TpzMnEj #Medications #healthcare
BLA submitted for Benlysta, a treatment for systemic lupus erythematosus (SLE) - MPR
empr.com — “Human Genome Sciences (HGS) announced that it has submitted a Biologics License Application (BLA) to the FDA for Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE).” View full resource at empr.com
Most Recently Shared on June 10, 2010 at 7:17 pm By:
MPR News: BLA submitted for Benlysta, a treatment for systemic lupus erythematosus (SLE): Human Genome Sciences (H... http://bit.ly/aMxmnn
BLA submitted for Benlysta, a treatment for systemic lupus erythematosus (SLE) - ONA
oncologynurseadvisor.com — “Human Genome Sciences (HGS) announced that it has submitted a Biologics License Application (BLA) to the FDA for Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE).” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 10, 2010 at 7:43 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
BLA submitted for Benlysta, a treatment for systemic lupus erythematosus (SLE) http://goo.gl/fb/1R7jn
Phase 3 study of Benlysta for systemic lupus erythematosus (SLE) - MPR
empr.com — “Human Genome Sciences and GlaxoSmithKline announced that Benlysta (belimumab, formerly LymphoStat-B) has met the primary endpoint in BLISS-52, a pivotal Phase 3, 52-week, multicenter, double-blind, placebo-controlled, superiority trial in patients with serologically active systemic lupus erythematosus (SLE).” View full resource at empr.com
Most Recently Shared on July 20, 2009 at 6:13 pm By:
MPR News: Phase 3 study of Benlysta for systemic lupus erythematosus (SLE): Human Genome Sciences and G.. http://bit.ly/10GfRn
Human Genome Sciences Announces Presentation Of Additional Phase 3 SLE Study Results For BENLYSTA® (Belimumab) At International Congress On SLE - TheStreet
thestreet.com — “Human Genome Sciences, Inc (Nasdaq:HGSI) today announced the presentation of additional results from BLISS-76, one of two pivotal Phase 3 trials of BENLYSTA® (belimumab) in seropositive patients with systemic.” View full resource at thestreet.com
Most Recently Shared on October 14, 2010 at 3:57 pm By:
Susan Scroggins Active Health Library and Health Advocate
Just added http://bit.ly/bgian0 to the BLISS-76 and Belimumab WisdomCard http://bit.ly/8Xt9r1 @organizedwisdom
Endpoints reached in second of two Phase 3 studies of Benlysta for systemic lupus erythematosus (SLE) - MPR
empr.com — “Human Genome Sciences and GlaxoSmithKline announced that Benlysta (belimumab, formerly LymphoStat-B) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE).” View full resource at empr.com
Most Recently Shared on November 2, 2009 at 5:05 pm By:
MPR News: Endpoints reached in second of two Phase 3 studies of Benlysta for systemic lupus erythematosus (SLE): Hum... http://bit.ly/47Khuh
Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting
news-medical.net — “Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.” View full resource at news-medical.net
Most Recently Shared on November 5, 2011 at 3:21 pm By:
Pregnancy News: Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting: Human Ge... http://t.co/Lh4mkMAs
Human Genome Sciences Announces Presentation of Additional Phase 3 SLE Study Results for BENLYSTA (Belimumab) | Lupus Research Institute
lupusresearchinstitute.org — “The Lupus Research Institute (LRI) provides LupusResearchInstitute.org to help scientists and physicians, patients, and their families champion novel and innovative lupus research. On the homepage you will find information about lupus and the LRI as well as lupus research and news.” View full resource at lupusresearchinstitute.org
Most Recently Shared on June 25, 2010 at 7:40 pm By:
News from #Lupus2010: HGS Announces Presentation of Additional Phase 3 SLE Study Results for BENLYSTA® http://ht.ly/23op4
Benlysta – The FDA approved it, but is it right for me? | S.L.E. Lupus Foundation
lupusny.org — “Benlysta – The FDA approved it, but is it right for me? | S.L.E. Lupus Foundation” View full resource at lupusny.org
Most Recently Shared on June 22, 2011 at 3:16 pm By:
The FDA approved Benlsyta, the first drug indicated for #lupus in over 55 years! But is it right for you? Get answers! http://ow.ly/5nPrF
BENLYSTA - New Product Releases - MPR
empr.com — “Systemic lupus erythematosus, in adults with active, autoantibody-positive SLE on standard therapy.” View full resource at empr.com
Most Recently Shared on April 1, 2011 at 2:10 pm By:
MPR News: BENLYSTA: Belimumab120mg/vial, 400mg/vial; pwd for IV infusion after reconÂstitution and dilution. http://bit.ly/dTrvvi
Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNF
hgsi.com — “Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNF” View full resource at hgsi.com
Most Recently Shared on March 10, 2011 at 1:06 am By:
Lupus Doctor Doctor, Internist, Rheumatologist, and Physician
Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNF
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Neurology OW
Organizing neurology resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Barbara J. Martin
Neurologist emeritus, Pathophilia blogger, noir lover
Advertisement
